Specific lifestyle changes can help individuals stay healthy and keep the weight off: Dose Tapering While patients can stop taking GLP-1s without serious side effects, it is critical to wean off the medication rather than stop taking it suddenly
An honest assessment of the evidence Here is the straight truth about probiotics and semaglutide
Survey results indicate that many employer plans require employees to complete a case management program or other utilization management steps before covering GLP-1 drugs
Ongoing phase 3 clinical trials are testing the medication for weight management, osteoarthritis, NAFLD, cardiovascular risk reduction, type 2 diabetes, and moderate to severe obstructive sleep apnea in obese and overweight patients
The physiological effects of endogenous intestinal GLP-1 on food intake and body weight are comparatively modest
5 Challenges and considerations Despite the tremendous promise of GLP-1-based therapies, challenges remain